Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Medically Reviewed by a Board-Certified Podiatrist

Table of Contents

• Understanding Raynaud Phenomenon
• Primary vs Secondary Raynaud’s
• How Vasospasm Affects Your Toes
• Symptoms and Color Change Patterns
• Common Triggers and Causes
• Diagnosis and Vascular Testing
• Complications and Digital Ulceration Risk
• Conservative Management Strategies
• Medical Treatment Options
• Michigan Winter Foot Protection
• Podiatrist-Recommended Products
• Most Common Mistake
• Warning Signs: When to See a Podiatrist
• Video Guide
• Frequently Asked Questions
• Sources
• Schedule an Appointment

Affiliate Disclosure: Some product links below are affiliate links, meaning we may earn a small commission if you purchase through them. This comes at no additional cost to you. We only recommend products we personally use in our clinical practice and believe will benefit our patients. Our recommendations are never influenced by affiliate relationships.

Understanding Raynaud Phenomenon in the Feet

Raynaud phenomenon is a vascular disorder characterized by episodic vasospasm—sudden narrowing of the small arteries supplying the toes—triggered primarily by cold exposure or emotional stress. Named after Maurice Raynaud who first described it in 1862, this condition affects approximately 3-5% of the general population, with women being five to nine times more likely to be affected than men. While Raynaud’s most commonly involves the fingers, the toes are affected in approximately 40% of patients, and in some cases the feet are the primary or only location of symptoms.

Living in Southeast Michigan presents particular challenges for patients with Raynaud phenomenon. Our winter temperatures regularly drop below freezing for months, and the combination of cold air temperatures with wet conditions creates an environment that maximally triggers vasospastic episodes. At Balance Foot & Ankle Specialists, we see a significant increase in Raynaud-related visits between November and March, with patients presenting with painful color changes, numbness, and in severe cases, digital ulceration from prolonged ischemia during cold exposure.

What makes Raynaud’s particularly concerning from a podiatric perspective is that the toes are already the most distal structures in the body, with the longest and most vulnerable arterial supply. Even without Raynaud’s, toe perfusion is lower than perfusion to more proximal tissues. When vasospasm is superimposed on this already-vulnerable circulation, the ischemic risk to the toes is significantly amplified—especially in patients with coexisting conditions like diabetes, peripheral arterial disease, or autoimmune disorders that independently compromise digital blood flow.

Primary vs Secondary Raynaud’s: Why the Distinction Matters

Primary Raynaud’s (also called Raynaud’s disease) occurs without an underlying associated condition and represents approximately 80% of all Raynaud cases. It typically presents in women between ages 15-30, produces symmetric color changes in multiple digits, and carries an excellent prognosis with no progression to tissue damage in the vast majority of patients. Primary Raynaud’s is essentially an exaggerated normal vasoconstrictive response to cold—the same mechanism the body uses to conserve core heat, but triggered at a lower threshold and with a more intense, prolonged vasospasm.

Secondary Raynaud’s (also called Raynaud’s phenomenon) occurs in association with an underlying connective tissue disease or other systemic condition and is the form that demands close monitoring and aggressive treatment. Scleroderma is the most strongly associated condition—over 90% of scleroderma patients develop Raynaud’s, often as the first symptom years before other manifestations appear. Systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, dermatomyositis, and mixed connective tissue disease all carry significant Raynaud’s associations. Secondary Raynaud’s tends to present later in life (over age 30), may be asymmetric, and carries a meaningful risk of digital ischemia, ulceration, and in extreme cases, gangrene.

Distinguishing primary from secondary Raynaud’s is critical because it determines monitoring intensity, treatment aggressiveness, and the need to screen for underlying autoimmune disease. The key clinical features suggesting secondary Raynaud’s include: onset after age 30, asymmetric involvement, severe episodes with digital ulceration, abnormal nailfold capillaroscopy (dilated or dropout capillaries), positive antinuclear antibody (ANA) or disease-specific autoantibodies, and elevated inflammatory markers. When we suspect secondary Raynaud’s, we coordinate with rheumatology for comprehensive autoimmune evaluation while simultaneously managing the vascular symptoms in the feet.

How Vasospasm Affects Your Toes

The pathophysiology of Raynaud phenomenon involves a complex interplay between the vascular endothelium, smooth muscle cells, neural regulation, and circulating factors. In normal cold response, the sympathetic nervous system releases norepinephrine, which activates alpha-2 adrenergic receptors on the smooth muscle cells surrounding digital arteries, causing vasoconstriction that redirects blood flow from the extremities to the core. In Raynaud’s, this response is amplified: the alpha-2 receptors are upregulated and hypersensitive, the endothelium produces insufficient vasodilatory nitric oxide, and the smooth muscle cells exhibit exaggerated contractility.

The characteristic triphasic color change reflects the progression of vascular events. The initial white phase (pallor) represents complete vasospasm with cessation of blood flow—the arterioles clamp shut, and the tissue becomes ischemic. The blue phase (cyanosis) follows as residual deoxygenated blood pools in the capillary beds, giving the toes a dusky bluish-purple appearance. The final red phase (rubor) occurs as the vasospasm releases and blood rushes back into the dilated, previously ischemic tissue. This reperfusion phase is often the most painful, producing throbbing, burning, and tingling as oxygen-rich blood returns to the ischemic tissue.

In secondary Raynaud’s, additional structural vascular changes compound the functional vasospasm. Intimal fibrosis (thickening of the inner arterial wall), thrombosis of digital arteries, and inflammatory infiltration of vessel walls reduce the baseline lumen diameter, meaning less vasospasm is needed to produce complete occlusion. This structural component explains why secondary Raynaud’s produces more severe episodes, longer recovery times, and a meaningful risk of fixed tissue damage including digital pitting scars, ulceration, and in extreme cases, gangrene requiring amputation.

Symptoms and Color Change Patterns in the Toes

The hallmark symptom is episodic color changes in the toes triggered by cold exposure. Not all patients experience the complete triphasic pattern—some experience only pallor and cyanosis (biphasic), while others may notice only the pallor phase. The color changes typically affect multiple toes simultaneously and are clearly demarcated from the normally-colored adjacent skin, creating a sharp line of demarcation that helps distinguish Raynaud’s from other causes of toe discoloration. The great toe may be spared while the lesser toes are affected, or all toes may change color simultaneously.

Accompanying sensory symptoms include numbness and tingling during the ischemic phase (white/blue), followed by burning, throbbing pain during the reperfusion phase (red). Some patients describe a “pins and needles” sensation as blood flow returns. The duration of episodes varies from minutes to hours, with primary Raynaud’s episodes typically resolving within 15-20 minutes of rewarming, while secondary Raynaud’s episodes may persist for an hour or more. Between episodes, the toes appear completely normal in primary Raynaud’s, but in secondary Raynaud’s, chronic changes including digital pitting, nail changes, and persistent cyanosis may develop over time.

Toe Raynaud’s presents unique challenges compared to finger involvement because the toes are enclosed in shoes and socks that can either protect from or contribute to cold exposure. Tight-fitting shoes or socks that compress the digital arteries can trigger or worsen vasospasm even without cold exposure. Conversely, the enclosed environment of properly fitted, insulated footwear can protect the toes from temperature triggers more effectively than gloves protect the fingers, making footwear management a cornerstone of Raynaud’s treatment in the feet.

Common Triggers and Causes of Raynaud’s in the Feet

Cold temperature exposure is the primary trigger, but the threshold varies significantly between patients. Some patients experience vasospasm when temperatures drop below 60°F (15°C), while others only trigger at near-freezing temperatures. In Michigan, the transition between heated indoor environments and cold outdoor temperatures creates repeated thermal cycling that can trigger multiple episodes daily during winter months. Even reaching into a refrigerator or freezer, walking on cold tile floors barefoot, or transitioning from a warm car to cold air can initiate an attack in sensitive individuals.

Emotional stress is the second most common trigger, operating through sympathetic nervous system activation that releases norepinephrine and triggers the same vasoconstrictive cascade as cold exposure. Medications that cause vasoconstriction—including beta-blockers, migraine medications containing ergotamine, certain ADHD medications, and decongestants containing pseudoephedrine—can precipitate or worsen Raynaud’s attacks. Nicotine is a potent vasoconstrictor, and smoking significantly worsens Raynaud’s symptoms while increasing the risk of digital ulceration in secondary Raynaud’s. Vibrating tools and repetitive trauma to the hands can trigger Raynaud’s, and similarly, prolonged standing on vibrating surfaces or repetitive foot impact can trigger toe vasospasm.

Secondary causes requiring investigation include scleroderma (the most common and most serious association), systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, dermatomyositis, mixed connective tissue disease, hypothyroidism, atherosclerotic peripheral arterial disease, thoracic outlet syndrome, carpal tunnel syndrome affecting the hands (and tarsal tunnel syndrome in the feet), blood disorders including cryoglobulinemia and polycythemia vera, and certain occupational exposures including vinyl chloride and heavy metals.

Diagnosis and Vascular Testing

Diagnosis of Raynaud phenomenon is primarily clinical, based on the characteristic history of episodic, cold-triggered color changes in the digits. The Allen criteria remain the diagnostic standard: definite Raynaud’s requires episodic attacks of acral (extremity) pallor or cyanosis provoked by cold or emotional stress. Patient photographs of attacks are invaluable because episodes rarely occur during office visits—we encourage patients to photograph their toes during an active episode to confirm the diagnosis and document the color change pattern.

Vascular assessment in the podiatric office includes palpation of pedal pulses (dorsalis pedis and posterior tibial), ankle-brachial index (ABI) measurement to screen for peripheral arterial disease, and toe-brachial index (TBI) to assess digital perfusion. In Raynaud’s, the ABI is typically normal (reflecting preserved large vessel flow), but the TBI may be reduced during or shortly after a vasospastic episode. Cold provocation testing—immersing the feet in cold water and measuring the time to color change and the recovery time after rewarming—can confirm the diagnosis and assess severity, though this test is uncomfortable and not routinely performed.

Laboratory evaluation for secondary causes includes antinuclear antibody (ANA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complete blood count, and disease-specific antibodies when clinical suspicion warrants (anti-centromere for limited scleroderma, anti-Scl-70 for diffuse scleroderma, anti-dsDNA for lupus). Nailfold capillaroscopy—examining the tiny capillaries at the base of the toenails under magnification—can distinguish primary from secondary Raynaud’s: normal capillary patterns suggest primary disease, while dilated, tortuous, or absent capillaries strongly suggest an underlying connective tissue disease.

Complications and Digital Ulceration Risk

The primary concern with Raynaud phenomenon is the risk of digital ischemia progressing to tissue necrosis. In primary Raynaud’s, this risk is extremely low—tissue damage is rare because the vasospasm resolves completely and the underlying vessels are structurally normal. However, in secondary Raynaud’s, the combination of functional vasospasm and structural vessel disease can produce prolonged ischemia sufficient to cause digital pitting scars (small depressed areas on the fingertips or toe tips from focal tissue loss), painful digital ulcers, and in severe cases, dry gangrene of the toe tip requiring amputation.

Digital ulcers in secondary Raynaud’s typically develop on the toe tips or over bony prominences where external pressure compounds the ischemic insult. These ulcers are extremely painful, slow to heal due to the underlying vascular compromise, and prone to secondary infection. In scleroderma patients, calcinosis (calcium deposits in the soft tissues) can erode through the skin creating additional ulceration sites. The healing time for Raynaud’s-related digital ulcers often exceeds 3-6 months, and some ulcers become chronic and recurrent despite optimal medical management.

Conservative Management Strategies

Cold avoidance is the foundational treatment for all Raynaud’s patients. For the feet, this means maintaining consistent toe warmth through properly insulated footwear, avoiding barefoot walking on cold surfaces, and minimizing transitions between warm and cold environments. Layered sock systems—a moisture-wicking inner layer topped by an insulating wool or synthetic outer layer—provide better thermal protection than a single thick sock. Heated insoles and battery-powered heated socks provide active warming for patients with severe cold sensitivity and are particularly valuable during Michigan winters.

Footwear selection is critical. Shoes must be roomy enough to avoid any compression of the toes—tight shoes that restrict blood flow can trigger vasospasm even in warm environments. Insulated, waterproof boots are essential for outdoor winter activities. The shoes should allow room for thick socks and orthotic insoles without creating pressure points. Avoid shoes with metal eyelets or other components that conduct cold to the foot. Chemical hand warmers (toe warmer versions) placed inside shoes provide supplemental heat during prolonged cold exposure and are an inexpensive, effective adjunct during winter months.

Lifestyle modifications include smoking cessation (essential—nicotine dramatically worsens vasospasm), regular aerobic exercise (which improves overall vascular function and peripheral blood flow), stress management techniques, and avoidance of vasoconstricting medications when possible. Dietary considerations include adequate omega-3 fatty acid intake (which may improve endothelial function) and avoidance of excessive caffeine, which has mild vasoconstrictive properties. Biofeedback training has shown promising results in some studies, teaching patients to consciously increase peripheral blood flow through relaxation techniques.

Medical Treatment Options for Raynaud’s

When conservative measures are insufficient, pharmacological treatment targets the vasospasm through several mechanisms. Calcium channel blockers—particularly nifedipine and amlodipine—are the first-line medical therapy, relaxing vascular smooth muscle to reduce both the frequency and severity of vasospastic episodes. Nifedipine extended-release at 30-60mg daily reduces attack frequency by approximately 33% and attack severity by approximately 50% in most studies. Side effects including headache, flushing, and peripheral edema limit tolerability in some patients.

Topical nitroglycerin applied to the affected toes provides local vasodilation without significant systemic effects. Compounded nitroglycerin ointment (0.5-2%) applied to the dorsum of the toes before cold exposure can prevent or shorten vasospastic episodes. Phosphodiesterase-5 inhibitors (sildenafil, tadalafil) have shown benefit in secondary Raynaud’s by enhancing nitric oxide-mediated vasodilation. For severe secondary Raynaud’s with digital ulceration, intravenous prostacyclin (iloprost) infusions can produce dramatic improvement by directly dilating digital arteries and inhibiting platelet aggregation.

In refractory cases with digital ischemia, sympathectomy—surgical or chemical interruption of the sympathetic nerve supply to the digital arteries—can provide relief. Digital sympathectomy (adventitial stripping of the digital arteries) is a microsurgical procedure that removes the sympathetic nerve fibers surrounding the affected arteries, reducing their ability to vasoconstrict. Botulinum toxin injection around the digital arteries has emerged as a less invasive alternative, providing temporary sympathetic blockade that can last 3-6 months per treatment.

Michigan Winter Foot Protection for Raynaud’s Patients

Michigan’s climate presents unique challenges for Raynaud’s patients. Average winter temperatures in Southeast Michigan hover around 25-35°F (-4 to 2°C) from December through February, with frequent dips below 10°F (-12°C) during cold snaps. The combination of cold air, wind chill, wet conditions from snow and slush, and the repeated thermal transitions between heated buildings and the outdoors creates a hostile environment for Raynaud’s-susceptible toes. We counsel our Raynaud’s patients to prepare for winter as a medical necessity, not merely a comfort preference.

A winter foot protection protocol for Michigan Raynaud’s patients includes: insulated waterproof boots rated to at least -20°F for all outdoor activities, layered moisture-wicking and insulating socks, chemical toe warmers for activities exceeding 15 minutes outdoors, pre-warming socks and boots before putting them on (place near a heat vent or use a boot dryer), starting calcium channel blocker medication in early November before the first sustained cold period, and keeping emergency warm footwear in the car for unexpected cold exposure. Remote car starters that pre-warm the vehicle before entering help avoid the cold car interior that triggers foot vasospasm during the daily commute.

Podiatrist-Recommended Products for Raynaud’s Patients

At Balance Foot & Ankle Specialists, we recommend specific products to help Raynaud’s patients maintain toe warmth, manage pain during vasospastic episodes, and support circulation throughout the day.

PowerStep Pinnacle Orthotic Insoles — Proper foot biomechanics reduce compensatory muscle tension that can contribute to vasospasm in the lower extremity. PowerStep orthotics provide arch support that distributes pressure evenly across the foot, preventing the focal pressure points that can compress digital arteries and trigger localized vasospasm. The cushioned design also provides insulation between the foot and cold ground surfaces during winter—an underappreciated benefit for Raynaud’s patients who experience attacks triggered by cold surfaces transmitting through thin shoe soles.

Doctor Hoy’s Natural Pain Relief Gel — The reperfusion phase of a Raynaud’s attack produces intense throbbing and burning pain as blood flow returns to the ischemic toes. Doctor Hoy’s provides targeted topical relief during this painful recovery period with its menthol component creating a gentle warming sensation that complements the natural rewarming process. Applied to the dorsum of the toes and forefoot after an episode resolves, Doctor Hoy’s manages the inflammatory component of reperfusion pain without the vasoconstricting effects that some oral anti-inflammatory medications can produce. The arnica component supports tissue recovery from the ischemic insult.

DASS Compression Socks — Graduated compression improves venous return and overall lower extremity circulation, which is beneficial for Raynaud’s patients between vasospastic episodes. DASS compression socks support baseline perfusion to the feet, helping maintain warmth and reduce the chronic swelling that some patients with secondary Raynaud’s develop from recurrent vascular inflammation. The consistent gentle compression also stabilizes the microvascular environment, potentially reducing the frequency of vasospastic triggers. For best results, warm the compression socks before applying them—cold compression fabric against Raynaud’s-susceptible toes can itself trigger an episode.

Most Common Mistake with Raynaud’s

Warning Signs: When to See a Podiatrist for Raynaud’s

Video Guide: Podiatrist-Recommended Foot Care Products

https://www.youtube.com/watch?v=A11FFjCXAX4

Frequently Asked Questions About Raynaud’s in the Feet

Is Raynaud’s in the feet dangerous?

Primary Raynaud’s affecting the feet is not dangerous—it causes discomfort but virtually never leads to tissue damage. However, secondary Raynaud’s associated with autoimmune conditions like scleroderma carries a real risk of digital ulceration and tissue loss. The key is determining whether your Raynaud’s is primary or secondary, which requires medical evaluation including blood tests and vascular assessment.

Can Raynaud’s cause permanent damage to toes?

In primary Raynaud’s, permanent toe damage is extremely rare. In secondary Raynaud’s, prolonged or severe vasospasm can cause digital pitting scars, chronic ulceration, and in extreme cases, gangrene requiring partial toe amputation. Early identification and aggressive treatment of secondary Raynaud’s significantly reduces the risk of permanent digital damage.

What is the best treatment for Raynaud’s in the feet?

Conservative treatment combining cold avoidance, proper insulated footwear, layered socks, and lifestyle modifications is effective for most patients with primary Raynaud’s. For moderate to severe cases, calcium channel blockers (nifedipine or amlodipine) are first-line medication. Topical nitroglycerin provides localized vasodilation. Severe secondary Raynaud’s may require prostacyclin infusions or surgical sympathectomy.

Why do my toes turn white in the cold?

White toes in the cold indicate vasospasm—the small arteries supplying your toes constrict excessively, cutting off blood flow and causing pallor. This is the ischemic phase of a Raynaud’s attack. If the white color resolves quickly with rewarming (within 15-20 minutes) and you experience no other symptoms, this is likely primary Raynaud’s. If episodes are prolonged, painful, or accompanied by other symptoms, seek evaluation.

Should I see a podiatrist or rheumatologist for Raynaud’s?

Both specialists play important roles. A podiatrist manages the foot-specific aspects including vascular assessment, footwear recommendations, digital ulcer care, and foot protection strategies. A rheumatologist evaluates for underlying autoimmune conditions causing secondary Raynaud’s and manages systemic immunosuppressive therapy. We often co-manage Raynaud’s patients with rheumatology for optimal outcomes.

Sources

1. Herrick AL. “Pathogenesis of Raynaud’s Phenomenon.” Rheumatology. 2005;44(5):587-596.
2. Wigley FM, Flavahan NA. “Raynaud’s Phenomenon.” New England Journal of Medicine. 2016;375(6):556-565.
3. Maverakis E, et al. “International Consensus Criteria for the Diagnosis of Raynaud’s Phenomenon.” Journal of Autoimmunity. 2014;48-49:60-65.
4. Hughes M, Herrick AL. “Raynaud’s Phenomenon.” Best Practice & Research Clinical Rheumatology. 2016;30(1):112-132.
5. Khouri C, et al. “Drug-Induced Raynaud’s Phenomenon: Beyond Beta-Adrenoceptor Blockers.” British Journal of Clinical Pharmacology. 2016;82(1):6-16.

Schedule Your Vascular Assessment

Related Foot Health Resources

• Podiatrist-Recommended Foot Care Products 2026
• Best Shoes for Plantar Fasciitis 2026
• Bunion Surgery Recovery Products 2026
• All Foot Care Articles

When to See a Podiatrist for Raynaud’s Foot Symptoms

If your toes turn white, blue, or red in response to cold or stress, you may have Raynaud’s phenomenon. A podiatrist can evaluate your circulation and recommend protective strategies. At Balance Foot & Ankle, we assess vascular foot conditions at our Howell and Bloomfield Hills offices.

Learn About Our Circulation & Vascular Assessment | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Wigley FM. “Raynaud’s phenomenon.” New England Journal of Medicine. 2002;347(13):1001-1008.
2. Herrick AL. “The pathogenesis, diagnosis and treatment of Raynaud phenomenon.” Nature Reviews Rheumatology. 2012;8(8):469-479.
3. Block JA, Sequeira W. “Raynaud’s phenomenon.” Lancet. 2001;357(9273):2042-2048.